Stay updated with breaking news from Pharma Neffy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. health regulators declined to approve a nasal spray that would have been the first needle-free emergency treatment for allergic reactions and asked for further tests, a move that left its...
The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for
Benzinga Elon Musk-Backed Brain Implant Firm Neuralink Starts Participant Enrollment In Brain Implant Human Trial For Paralysis Elon Musk's brain-computer interface company, Neuralink, has initiated recruiting its first test subjects for human trials aimed at assisting individuals with paralysis in controlling devices. Neuralink announced that it has obtained approval from an independent institutional review board and the initial hospital site, enabling the commencement of recruitment for its fi
As August draws to a close, let's turn our attention to the list of companies eagerly anticipating the FDA's verdict in September..